UK probing Novo's Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughts
Between 2020 and July 6 this year, the MHRA received five reports of suspected adverse drug reactions involving semaglutide associated with "suicidal and self-injurious behavior."
Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly, is seen at a Rock Canyon Pharmacy in Provo, Utah, US March 29, 2023.(photo credit: REUTERS/GEORGE FREY)ByREUTERS